Anti-Glucose 6 Phosphate Dehydrogenase antibody [EPR6292]
- RabMAb
- Recombinant
- What is this?
5
(1 Review)
|
(23 Publications)
Rabbit Recombinant Monoclonal Glucose 6 Phosphate Dehydrogenase antibody. Suitable for IHC-P, WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 23 publications.
View Alternative Names
Glucose-6-phosphate 1-dehydrogenase, G6PD
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Glucose 6 Phosphate Dehydrogenase antibody [EPR6292] (AB133525)
Immunohistochemistry analysis of Paraffin Embedded Human testis tissue labelling Glucose 6 Phosphate Dehydrogenase with ab133525 at 1/50.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-Glucose 6 Phosphate Dehydrogenase antibody [EPR6292] (AB133525)
Flow Cytometry analysis of A549 (Human lung carcinoma epithelial cell) cells labeling Glucose 6 Phosphate Dehydrogenase with purified ab133525 at 1/1000 dilution (1 μg/mL) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- WB
Unknown
Western blot - Anti-Glucose 6 Phosphate Dehydrogenase antibody [EPR6292] (AB133525)
All lanes:
Western blot - Anti-Glucose 6 Phosphate Dehydrogenase antibody [EPR6292] (ab133525) at 1/1000 dilution
Lane 1:
Molt 4 cell lysate at 10 µg
Lane 2:
A549 cell lysate at 10 µg
Lane 3:
MCF7 cell lysate at 10 µg
Lane 4:
HeLa cell lysate at 10 µg
Lane 5:
HepG2 cell lysate at 10 µg
Secondary
All lanes:
Goat anti-rabbit at 1/2000 dilution
Predicted band size: 59 kDa
Observed band size: 58 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-Glucose 6 Phosphate Dehydrogenase antibody [EPR6292] (AB133525)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (3)
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Glucose 6 Phosphate Dehydrogenase antibody [EPR6292]
-
Anti-Glucose 6 Phosphate Dehydrogenase antibody [EPR6292] - BSA and Azide free
-
519 Alexa Fluor® 488
Anti-Glucose 6 Phosphate Dehydrogenase antibody [EPR6292] (Alexa Fluor® 488)
Reactivity data
Product details
Cellular localisation: centrosome, cytosol, internal side of plasma membrane, intracellular membrane bounded organelle. There are 3 isoforms produced by alternative splicing.
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Glucose 6-phosphate dehydrogenase is essential for maintaining cellular redox balance especially in cells lacking mitochondria like red blood cells. It functions as part of a monomer which can dimerize depending on the cellular needs and conditions. The activity of G6PD directly affects the production of NADPH which is necessary for the biosynthesis of nucleic acids and lipids and for maintaining reduced glutathione levels therefore sustaining the antioxidant capacity of the cell.
Pathways
Glucose 6-phosphate dehydrogenase is a pivotal enzyme in the oxidative phase of the pentose phosphate pathway which provides ribose 5-phosphate for nucleotide synthesis and NADPH for reductive biosynthetic reactions. G6PD connects with other enzymes in the pathway such as 6-phosphogluconate dehydrogenase contributing to the regulation of cellular metabolic needs. Its function is tightly linked to glucose metabolism and indirectly influences glycolytic processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (23)
Recent publications for all applications. Explore the full list and refine your search
Journal of translational medicine 23:679 PubMed40533802
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:3932 PubMed40287409
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 16:1563865 PubMed40166471
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 15:670 PubMed39266534
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:110045 PubMed38947529
2024
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 43:2337-2367 PubMed38649537
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed36142502
2022
Applications
Unspecified application
Species
Unspecified reactive species
Acta pharmaceutica Sinica. B 12:1871-1884 PubMed35847493
2022
Applications
Unspecified application
Species
Unspecified reactive species
Antioxidants (Basel, Switzerland) 11: PubMed35453346
2022
Applications
Unspecified application
Species
Unspecified reactive species
Pathology oncology research : POR 28:1610231 PubMed35392503
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com